Jiangsu Nhwa Pharmaceutical Co., Ltd.

China

Drug Substance

Drug Product

Advanced Modalities

Clinical Trial Supply & Logistics

Company Overview

About

Jiangsu Nhwa Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in CNS (Central Nervous System) drugs, listed on Shenzhen Stock Exchange (002262.SZ) since 2008. Founded in 1978, the company is designated as a national production unit for narcotic and psychotropic drugs. Nhwa operates over 10 automated production lines for tablets, capsules, liquid injectables, and powder injectables, covering over 800 acres. The company serves as a major global CNS drug production and R&D base.

Key Expertise

CNS drug manufacturing, narcotic and psychotropic drug production, anesthesia drugs, psychiatric medications, neurological medications

Therapeutic Areas

CNS (Central Nervous System)

Psychiatry

Neurology

Cardiovascular

Metabolic Disease

Oncology

Quick Facts

HQ:China

Capabilities & Services

Core Capabilities

Small Molecule API
Small Molecule Drug Product
Oral Solid Dose

Dosage Forms

Oral Solid Dose

Sterile Injectable

Containment Capabilities

DEA Schedule II-V

Production Scales

Commercial Scale

Large Scale (Metric Ton+)

Annual Capacity

Commercial (1,000 - 10,000 kg/year)

Large Commercial (> 10,000 kg/year)

Markets Served

Asia

Manufacturing Facilities

1 site worldwide